Cathay Biotech Inc.

Industrial biotech


HBM contact: Dr Ivo Staijen

Company status: public

 Cathay has realized commercial-scale production of revolutionary products, including bio-based polyamide,bio-based DN5 (1,5-pentanediamine), long chain dibasic acids (LCDA) and biobutanol.In recent years, Cathay has successfully developed the DN5 via bio-manufacturing and produced downstream bio-based polyamide with extraordinary performance benefits.

© HBM Partners AG  |  Bundesplatz 1  |  6300 Zug, Switzerland  |  Phone  +41 43 888 7171